These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38339027)

  • 1. Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation.
    Székely A; Pállinger É; Töreki E; Ifju M; Barta BA; Szécsi B; Losoncz E; Dohy Z; Barabás IJ; Kosztin A; Buzas EI; Radovits T; Merkely B
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation.
    Pállinger É; Székely A; Töreki E; Bencsáth EZ; Szécsi B; Losoncz E; Oleszka M; Hüttl T; Kosztin A; Buzas EI; Radovits T; Merkely B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart re-transplantation in Eurotransplant.
    Smits JM; De Pauw M; Schulz U; Van Cleemput J; Raake P; Knezevic I; Caliskan K; Sutlic Z; Knosalla C; Schoenrath F; Szabolcs Z; Gottlieb J; Hagl C; Doesch A; Baric D; Rudez I; Strelniece A; De Vries E; Green D; Samuel U; Milicic D; Hartyanszky I; Berchtold-Herz M; Schulze PC; Mohr F; Meiser B; Haverich A; Reichenspurner H; Gummert J; Laufer G; Zuckermann A
    Transpl Int; 2018 Nov; 31(11):1223-1232. PubMed ID: 29885002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk.
    Moayedi Y; Rodenas-Alesina E; Mueller B; Fan CS; Cherikh WS; Stehlik J; Teuteberg JJ; Ross HJ; Khush KK
    Circ Heart Fail; 2023 May; 16(5):e009994. PubMed ID: 37192289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation.
    Loforte A; Murana G; Cefarelli M; Jafrancesco G; Sabatino M; Martin Suarez S; Pilato E; Pacini D; Grigioni F; Bartolomeo RD; Marinelli G
    Artif Organs; 2016 Aug; 40(8):E136-45. PubMed ID: 27530673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor.
    Takahashi T; Terada Y; Pasque MK; Itoh A; Nava RG; Puri V; Kreisel D; Patterson AG; Hachem RR
    Clin Transplant; 2020 Jan; 34(1):e13768. PubMed ID: 31833584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term results of heart transplantation using donors over 63 years of age.
    Potapov EV; Loebe M; Hübler M; Musci M; Hummel M; Weng Y; Hetzer R
    Transplantation; 1999 Dec; 68(12):1834-8. PubMed ID: 10628759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.
    Seguchi O; Fujita T; Murata Y; Sunami H; Sato T; Watanabe T; Nakajima S; Kuroda K; Hisamatsu E; Sato T; Yanase M; Hata H; Wada K; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Heart Vessels; 2016 Apr; 31(4):555-62. PubMed ID: 25682298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normothermic ex vivo allograft blood perfusion in clinical heart transplantation.
    Koerner MM; Ghodsizad A; Schulz U; El Banayosy A; Koerfer R; Tenderich G
    Heart Surg Forum; 2014 Jun; 17(3):E141-5. PubMed ID: 25002389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury.
    Karamlou T; Shen I; Slater M; Crispell K; Chan B; Ravichandran P
    J Heart Lung Transplant; 2005 Jan; 24(1):29-33. PubMed ID: 15653375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients.
    Grupper A; AbouEzzeddine OF; Maleszewski JJ; Grupper A; Geske JR; Kremers WK; Kushwaha SS; Pereira NL
    Clin Transplant; 2018 Sep; 32(9):e13349. PubMed ID: 29998506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe primary graft dysfunction of the heart transplant is associated with increased plasma and intragraft proinflammatory cytokine expression.
    Holmström EJ; Syrjälä SO; Dhaygude K; Tuuminen R; Krebs R; Nykänen A; Lemström KB
    J Heart Lung Transplant; 2023 Jun; 42(6):807-818. PubMed ID: 36754701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric heart transplantation: 23-year single-center experience.
    Huebler M; Schubert S; Lehmkuhl HB; Weng Y; Miera O; Alexi-Meskishvili V; Berger F; Hetzer R
    Eur J Cardiothorac Surg; 2011 May; 39(5):e83-9. PubMed ID: 21354807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbances in iron homeostasis result in accelerated rejection after experimental heart transplantation.
    Resch T; Ashraf MI; Ritschl PV; Ebner S; Fabritius C; Brunner A; Schäfer G; Regele H; Günther J; Weiss G; Kotsch K
    J Heart Lung Transplant; 2017 Jul; 36(7):732-743. PubMed ID: 28372951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ Dysfunction and Failure Following Brain Death Do Not Preclude Successful Donation.
    Essien EI; Parimi N; Gutwald-Miller J; Nutter T; Scalea TM; Stein DM
    World J Surg; 2017 Nov; 41(11):2933-2939. PubMed ID: 28620674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.